EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Feasibility of quality indicators to assess the prevalence of guideline adherence in a german cohort of patients with advanced or metastatic breast cancer: Results of the BRE-BY-MED study

Lilly Sophia Brandstetter, Anna Grau, Max Müller-Reiter, Jessica Salmen, Jens-Peter Reese, Peter U Heuschmann, Achim Wöckel

Cancer Treatment and Research Communications · 2026 · 47 · 101200

DOI: 10.1016/j.ctarc.2026.101200 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Lilly Sophia Brandstetter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Epidemiology and Biometry, Julius-Maximilian University Würzburg, Würzburg, Germany. Electronic address: lilly.brandstetter@un…. Hauptthemen laut MEDLINE: Guideline Adherence, Breast Neoplasms, Quality Indicators, Health Care. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Berlin Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Guideline AdherenceBreast NeoplasmsQuality Indicators, Health CareHumansFemaleMiddle AgedGermanyFeasibility StudiesPractice Guidelines as TopicCohort StudiesNeoplasm MetastasisAgedPrevalence

Stichwörter der Autor:innen

Breast cancerGuideline adherenceMetastatic breast cancerQuality indicatorsRoutine medical recordsTreatment guidelines

Autor:innen und Institutionen

  • Institute for Clinical Epidemiology and Biometry, Julius-Maximilian University Würzburg, Würzburg, Germany. Electronic address: lilly.brandstetter@uni-wuerzburg.de.
  • Institute for Clinical Epidemiology and Biometry, Julius-Maximilian University Würzburg, Würzburg, Germany.
  • Department of Gynaecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.
  • Institute for Clinical Epidemiology and Biometry, Julius-Maximilian University Würzburg, Würzburg, Germany; Institute of medical Data Science, University Hospital Würzburg, Germany; Faculty of Health Sciences, Technisch…
  • Institute for Clinical Epidemiology and Biometry, Julius-Maximilian University Würzburg, Würzburg, Germany; Institute of medical Data Science, University Hospital Würzburg, Germany; Clinical Trial Centre Würzburg, Unive…

Förderung

  • Berlin Institute of Health

Zitieren

APA

Brandstetter, L. S., Grau, A., Müller-Reiter, M., Salmen, J., Reese, J. P., Heuschmann, P. U., & Wöckel, A. (2026). Feasibility of quality indicators to assess the prevalence of guideline adherence in a german cohort of patients with advanced or metastatic breast cancer: Results of the BRE-BY-MED study. Cancer Treatment and Research Communications, 47, 101200. https://doi.org/10.1016/j.ctarc.2026.101200

Vancouver

Brandstetter LS, Grau A, Müller-Reiter M, Salmen J, Reese JP, Heuschmann PU, et al. Feasibility of quality indicators to assess the prevalence of guideline adherence in a german cohort of patients with advanced or metastatic breast cancer: Results of the BRE-BY-MED study. Cancer Treatment and Research Communications. 2026;47:101200. doi:10.1016/j.ctarc.2026.101200

BibTeX
@article{Brandstetter2026,
  author = {Brandstetter, Lilly Sophia and Grau, Anna and Müller-Reiter, Max and Salmen, Jessica and Reese, Jens-Peter and Heuschmann, Peter U and Wöckel, Achim},
  title = {Feasibility of quality indicators to assess the prevalence of guideline adherence in a german cohort of patients with advanced or metastatic breast cancer: Results of the BRE-BY-MED study},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  volume = {47},
  pages = {101200},
  doi = {10.1016/j.ctarc.2026.101200}
}
Kostenlos starten →